event presence logo
Going All In on Management, Monitoring, and More in Diabetes Practice

CPE

MGM Grand Conference Center
Wednesday, October 16, 2024 | 12:00 PM - 01:00 PM PT
Supported by an independent educational grant from Abbott Diabetes Care.

overview

The use of diabetes devices can help people with type 2 diabetes (T2D) reach glycemic goals, yet the use remains largely suboptimal. Are you up to date on current recommendations for T2D diabetes monitoring and management, including standards of care and Healthcare Effectiveness Data and Information Set (HEDIS) measures? Join us during this live 60-minute certified symposium and interact with our 3 expert faculty by participating in case studies, submitting questions, and using real-time polling to learn how you can improve health care for all people with T2D. Register to reserve your spot!

faculty

CHAIRPERSON

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist

Director, Education & Training in Diabetes Technology

Co-Director, Endocrine Disorders in Pregnancy

Cleveland Clinic Endocrinology & Metabolism Institute

Cleveland, Ohio

FACULTY

Eden M. Miller, DO, D-ABOM, D-ACD

Chief Executive Officer

Diabetes and Obesity Care

Bend, Oregon

FACULTY

Jennifer Goldman, PharmD, CDCES, BC‑ADM, FCCP

Professor of Pharmacy Practice

Massachusetts College of Pharmacy and Health Sciences

Boston, Massachusetts

Clinical Pharmacist

Well Life

Peabody, Massachusetts

AGENDA

11:30 am

Lunch and Registration

12:00 pm

Welcome and Introductions

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
12:05 pm

Updates in Quality Metrics Related to Diabetes Management

Jennifer Goldman, PharmD, CDCES, BC‑ADM, FCCP
12:20 pm

Updates in the Role of Continuous Glucose Monitoring (CGM) in Patients With Type 2 Diabetes

Eden M. Miller, DO, D-ABOM, D-ACD
12:35 pm

Updates in the Role of Automated Insulin Delivery (AID) and Continuous Ketone Monitoring (CKM) in Patients With Diabetes

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
12:50 pm

Closing Remarks and Q&A

All Faculty

LOCATION

MGM Grand Conference Center

4701 Koval Lane, Las Vegas, Nevada, 89109

Room: Terrace 153

GOAL STATEMENT

The goal of this activity is for learners to be better able to apply updated recommendations for the treatment and monitoring of type 2 diabetes (T2D) in their practice.

TARGET AUDIENCE

This activity is intended for managed care pharmacists and other managed care professionals.

LEARNING OBJECTIVES

Upon completion of this activity, participants will: [break] [break] Have increased knowledge regarding the [LIST] [ITEM]Updated quality metrics related to successful diabetes management [ITEM]Updates in the role of automated insulin delivery (AID) and continuous ketone monitoring (CKM) in patients with diabetes from a payer perspective [ITEM]New data supporting the role and use of continuous glucose monitoring (CGM) in patients with T2D [/LIST] [break] Demonstrate greater confidence in their ability to [LIST] [ITEM]Appreciate the value of new technologies for diabetes assessment and monitoring[/LIST]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
accreditation logo
medscape logo
For Pharmacists [break] Medscape designates this continuing education activity for 1.0 contact hour(s) (0.100 CEUs) (Universal Activity Number: JA0007105-0000-24-304-L01-P).
© 2024 MedscapeLIVE! All Rights Reserved | Medscape Education Terms of Service | Privacy Policy